adenosine diphosphate has been researched along with simvastatin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichihara, K; Satoh, K | 1 |
Ichihara, K; Nakai, T; Satoh, K | 1 |
Belenkov, YN; Kaminnaya, VI; Konovalova, GG; Lankin, VZ; Pisarenko, OI; Studneva, IM; Tikhaze, AK | 1 |
Balduini, CL; Dunzendorfer, S; Egger, P; Gritti, D; Kaneider, NC; Noris, P; Ricevuti, G; Wiedermann, CJ | 1 |
Dunzendorfer, S; Egger, P; Kaneider, NC; Wiedermann, CJ | 1 |
Bestehorn, HP; Büttner, HJ; Frundi, D; Hochholzer, W; Neumann, FJ; Stratz, C; Trenk, D; Valina, CM | 1 |
Fefer, P; Hod, H; Matetzky, S; Novikov, I; Savion, N; Shechter, M; Shenkman, B; Varon, D | 1 |
Anderson, EJ; Bamman, MM; Cortright, RN; Kane, DA; Kwak, HB; Lee, NS; Lin, CT; Neufer, PD; Thalacker-Mercer, A | 1 |
Jalkanen, S; Loukovaara, S; Tuuminen, R; Yegutkin, GG | 1 |
1 trial(s) available for adenosine diphosphate and simvastatin
Article | Year |
---|---|
Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Atorvastatin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Coronary Disease; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Female; Flow Cytometry; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Pyrroles; Simvastatin; Stents; Ticlopidine; Time Factors; Treatment Outcome | 2008 |
8 other study(ies) available for adenosine diphosphate and simvastatin
Article | Year |
---|---|
Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in ischemic rat hearts.
Topics: Adenosine Diphosphate; Animals; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lovastatin; Male; Mitochondria, Heart; Myocardial Ischemia; Oxygen Consumption; Pravastatin; Rats; Rats, Sprague-Dawley; Simvastatin | 1995 |
Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on mitochondrial respiration in rat liver during ischemia.
Topics: Adenosine Diphosphate; Animals; Cell Fractionation; Glutamic Acid; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Liver; Lovastatin; Male; Mitochondria, Liver; Oxygen Consumption; Pravastatin; Rats; Rats, Sprague-Dawley; Simvastatin; Succinates | 1994 |
Inhibitor of beta-hydroxy-beta-methylglutaryl coenzyme A reductase decreases energy supply to the myocardium in rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Creatine; Enzyme Inhibitors; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Male; Myocardium; Phosphocreatine; Rats; Rats, Wistar; Simvastatin | 2001 |
Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Antigens, CD; Apyrase; Blood Platelets; Cell Separation; Cells, Cultured; Culture Media, Conditioned; Endothelium, Vascular; Enzyme Reactivators; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Platelet Aggregation; Pyridines; rho GTP-Binding Proteins; Simvastatin; Thrombin; Time Factors; Umbilical Veins | 2002 |
Rho-GTPase-dependent platelet-neutrophil interaction affected by HMG-CoA reductase inhibition with altered adenosine nucleotide release and function.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Blood Platelets; Cell Communication; Cell Separation; Chemotactic Factors; Culture Media, Conditioned; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neutrophil Activation; Neutrophils; Platelet Activation; Purinergic P2 Receptor Antagonists; Pyridines; Reactive Oxygen Species; Receptors, Purinergic P2; Respiratory Burst; rho GTP-Binding Proteins; Signal Transduction; Simvastatin; Thrombin; Trypan Blue | 2002 |
Statins have an early antiplatelet effect in patients with acute myocardial infarction.
Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Arachidonic Acid; Blood Platelets; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Function Tests; Pravastatin; Simvastatin | 2011 |
Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes.
Topics: Adenosine Diphosphate; Anticholesteremic Agents; Apoptosis; Cell Differentiation; Cell Respiration; Dose-Response Relationship, Drug; Electron Transport Complex I; Gene Expression; Humans; Hydrogen Peroxide; Mitochondria; Muscle Fibers, Skeletal; Muscular Diseases; Myoblasts; Oxidative Stress; Oxygen Consumption; Primary Cell Culture; Proto-Oncogene Proteins c-bcl-2; Respiratory System Agents; Signal Transduction; Simvastatin; Superoxides | 2012 |
Simvastatin use associated with low intraocular ADP levels in patients with sight-threatening diabetic retinopathy.
Topics: Adenosine Diphosphate; Animals; Biomarkers; Cells, Cultured; Diabetic Retinopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Retina; Simvastatin | 2016 |